# Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

> **NCT00185523** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 88 (actual)

## Conditions studied

- Leukemia, Lymphocytic, Acute
- Leukemia
- Leukemia Acute Promyelocytic Leukemia (APL)
- Leukemia Acute Lymphoid Leukemia (ALL)
- Leukemia Chronic Myelogenous Leukemia (CML)
- Leukemia Acute Myeloid Leukemia (AML)
- Leukemia Chronic Lymphocytic Leukemia (CLL)

## Interventions

- **PROCEDURE:** Allogeneic hematopoietic cell transplantation

## Key facts

- **NCT ID:** NCT00185523
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2002-05
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185523, "Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00185523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*